Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL †

SIMPLE SUMMARY: PRESERV MEL (Prospective and REtrospective Study of nivolumab thERapy in adjuVant MELanoma) is a real-world observational study evaluating the effectiveness and safety of adjuvant nivolumab in patients with completely resected stage III or stage IV melanoma in clinical practice in Be...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogiers, Anne, Willemot, Laurence, McDonald, Laura, Van Campenhout, Hilde, Berchem, Guy, Jacobs, Celine, Blockx, Nathalie, Rorive, Andrée, Neyns, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572061/
https://www.ncbi.nlm.nih.gov/pubmed/37835517
http://dx.doi.org/10.3390/cancers15194823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572061/
https://www.ncbi.nlm.nih.gov/pubmed/37835517
http://dx.doi.org/10.3390/cancers15194823

Ejemplares similares